Our Story

Spectral AI is an artificial intelligence company focusing on medical diagnostics, predictive analytics, and ‘Day One’ healing predictions.

  1. 2013

    Spectral AI Incorporated

  2. 2014

    DeepView Generation 1 510(k) clearance

  3. 2015

    First BARDA Contract

  4. 2016

    DeepView Generation 2 (510k) clearance

  5. 2017

    First Defense Health Agency Contract

  6. 2018

    FDA Breakthrough Designation – Burn

  7. 2019

    Burn Proof Concept Clinical Study Initiated

  8. 2020

    DFU Proof of Concept Clinical Study Initiated

  9. 2021

    Secondary BARDA Burn Contract

  10. 2021

    Burn AI Training Study Initiated

  11. 2021

    Admission to Trading on AIM London Exchange

  12. 2021

    First Department of Defense Contract

  13. 2022

    DFU Validation Study Initiated

  14. 2023

    EU DFU Clinical Study Initiation

  15. 2023

    US Burn AI training Study Completed

  16. 2023

    Business Combination Agreement

At The Forefront
of Innovation

Provides faster and more accurate treatment insight, significantly improving patient care and clinical outcomes.

Dot pattern

Let’s Talk

Want to Learn More About Spectral AI, DeepView®, and our Team?